Allspring Global Investments
DTIL icon

Allspring Global Investments’s Precision BioSciences DTIL Stock Holding History

Allspring Global Investments’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-621
Closed -$24K – 2911
2022
Q3 		$24K Buy
621
+189
+44% +$8.98K ﹤0.01% 2580
2022
Q2 		$20K Sell
432
-2,319
-84% -$136K ﹤0.01% 2485
2022
Q1 		$254K Buy
2,751
+362
+15% +$49.2K ﹤0.01% 2492
2021
Q4 		$530K Buy
+2,389
New +$667K ﹤0.01% 2261

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Allspring Global Investments's DTIL Position: Q4 2022 in Review

Allspring Global Investments sold out of Precision BioSciences (DTIL) in Q4 2022, closing a stake of 621 shares — an estimated $24K sold.

Allspring Global Investments first reported a position in DTIL in Q4 2021 and held it in 4 quarters. The position peaked at $530K in Q4 2021. 100 funds tracked by Wall St. Rank hold DTIL as of Q4 2022.

  • Allspring Global Investments reported no remaining Precision BioSciences position as of Q4 2022 after selling out during the quarter.
  • Allspring Global Investments sold 621 Precision BioSciences shares in Q4 2022, an estimated $24K.
  • Allspring Global Investments first reported a position in Precision BioSciences in Q4 2021 and held it in 4 quarters.
  • Allspring Global Investments's Precision BioSciences position peaked at $530K in Q4 2021.
  • 100 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2022.

Based on Allspring Global Investments's 13F filing for Q4 2022, filed 23 Jan 2023.